Our latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...
Read moreKey findings from the ABPI's latest report highlight challenges and opportunities in NICE's health t...
Read moreAs the focus on sustainability grows, manufacturers will need to address their products’ environme...
Read moreThe Spanish Ministry of Health's Draft Royal Decree on HTA reshapes assessments, aligning with EU-H...
Read moreThe collaboration is aimed at enhancing HTA reports, facilitating resource and knowledge sharing and...
Read moreNew doctrine accelerates drug development for rare diseases and oncology by adjusting evidence requi...
Read moreWe summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...
Read moreWe discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...
Read moreLearn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...
Read moreOur experts analyse how local European markets are integrating the EU HTA outputs into national proc...
Read more